Sio Gene Therapies (NASDAQ:SIOX) reported quarterly losses of $(0.16) per share. This is a 20 percent increase over losses of $(0.20) per share from the same period last year.
MeridianLink Q3 Adj. EPS $0.06 Beats $0.03 Estimate, Sales $67.40M Beat $63.12M Estimate
MeridianLink (NYSE:MLNK) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.03 by 100 percent. The company reported quarterly sales of $67.40 million which beat the analyst
